Calliditas Therapeutics: Our take on today news
Research Note
2020-06-01
14:33
Redeye repeats its positive view of Calliditas following todays press release regarding the launch of US IPO roadshow and the targeted capital raise of USD 75 million.
LS
Ludvig Svensson
Disclosures and disclaimers